TXNDC5 protects synovial fibroblasts of rheumatoid arthritis from the detrimental effects of endoplasmic reticulum stress. 2020

Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
School of Medicine and Life Sciences, University of Ji'nan-Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.

TXNDC5 is an endoplasmic reticulum (ER)-resident chaperone that protects the endothelium from secondary effects of ER stress. Previous studies by the current authors identified TXNDC5 as a key pathological factor in promoting the inflammatory phenotype of fibroblast-like synoviocytes (FLSs) from rheumatoid arthritis (RA). However, its activity in RA FLSs under ER stress remains unclear. The current study found that TXNDC5 is responsive to ER stress in RA FLSs since its expression was induced by ER stress at both the endogenous and secretory level. A functional study indicated that silencing TXNDC5 reduced the viability of RA FLSs more markedly in the presence of ER stressors. In contrast, rhTXNDC5 attenuated a decrease in cell viability as a result of ER stress. Moreover, silencing TXNDC5 attenuated the induction of IL-6 and IL-8 from RA FLSs in response to ER stress. In addition, rhTXNDC5 induced a greater increase in VEGF production during ER stress. These findings confirm the pro-survival and pro-inflammation roles of TXNDC5 under ER stress in RA FLSs. TXNDC5 appears to act as a mediator linking ER stress and inflammation of RA.

UI MeSH Term Description Entries

Related Publications

Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
July 2022, Annals of translational medicine,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
January 2014, Journal of Korean medical science,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
January 2010, Arthritis research & therapy,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
July 2018, Cellular & molecular immunology,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
January 1984, Scandinavian journal of rheumatology,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
November 2023, Biomedicines,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
October 2011, Neuroscience letters,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
January 2015, Current pharmaceutical design,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
June 1995, Annals of the rheumatic diseases,
Qiqi Lu, and Jinguang Wang, and Xiumei Zhang, and Ruisong Tian, and Li Qiao, and Luna Ge, and Jihong Pan, and Lin Wang
March 2021, The Journal of clinical investigation,
Copied contents to your clipboard!